Basilea Pharmaceutica AG (BSLN) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.305x

Based on the latest financial reports, Basilea Pharmaceutica AG (BSLN) has a cash flow conversion efficiency ratio of 0.305x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF39.03 Million ≈ $49.35 Million USD) by net assets (CHF127.94 Million ≈ $161.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Basilea Pharmaceutica AG for the company's overall valuation and market capitalisation.

Basilea Pharmaceutica AG - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Basilea Pharmaceutica AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Basilea Pharmaceutica AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Basilea Pharmaceutica AG ranked by their cash flow conversion efficiency. Explore Basilea Pharmaceutica AG (BSLN) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Shanghai Shenda Co Ltd SHG:600626	0.042x
Hana Materials Inc KQ:166090	0.064x
Air New Zealand Ltd AU:AIZ	0.117x
Shenzhen Prince New Materials Co Ltd SHE:002735	0.021x
Zhengping Road&Bridge Constr SHG:603843	-0.011x
Gansu Dunhuang Seed Co Ltd SHG:600354	0.178x
Bloomin Brands Inc NASDAQ:BLMN	0.209x
Baskent Dogalgaz Dagitim Gayrimenkul Yatirim Ortakligi AS IS:BASGZ	0.041x

Annual Cash Flow Conversion Efficiency for Basilea Pharmaceutica AG (2002–2025)

The table below shows the annual cash flow conversion efficiency of Basilea Pharmaceutica AG from 2002 to 2025. View Basilea Pharmaceutica AG (BSLN) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CHF127.94 Million ≈ $161.75 Million	CHF62.09 Million ≈ $78.50 Million	0.485x	-47.14%
2024-12-31	CHF81.00 Million ≈ $102.40 Million	CHF74.36 Million ≈ $94.01 Million	0.918x	+164.47%
2023-12-31	CHF-10.00 Million ≈ $-12.65 Million	CHF14.24 Million ≈ $18.01 Million	-1.424x	-318.08%
2022-12-31	CHF-20.71 Million ≈ $-26.19 Million	CHF7.06 Million ≈ $8.92 Million	-0.341x	-162.35%
2021-12-31	CHF-58.61 Million ≈ $-74.10 Million	CHF-32.02 Million ≈ $-40.48 Million	0.546x	+2.99%
2020-12-31	CHF-102.05 Million ≈ $-129.01 Million	CHF-54.13 Million ≈ $-68.44 Million	0.530x	-22.75%
2019-12-31	CHF-92.96 Million ≈ $-117.53 Million	CHF-63.84 Million ≈ $-80.71 Million	0.687x	-42.19%
2018-12-31	CHF-66.69 Million ≈ $-84.31 Million	CHF-79.21 Million ≈ $-100.14 Million	1.188x	+358.87%
2017-12-31	CHF-41.44 Million ≈ $-52.39 Million	CHF19.01 Million ≈ $24.04 Million	-0.459x	-121.41%
2016-12-31	CHF-35.00 Million ≈ $-44.25 Million	CHF-75.00 Million ≈ $-94.82 Million	2.143x	+146.97%
2015-12-31	CHF14.86 Million ≈ $18.78 Million	CHF-67.78 Million ≈ $-85.69 Million	-4.562x	-269.86%
2014-12-31	CHF57.93 Million ≈ $73.24 Million	CHF-71.46 Million ≈ $-90.35 Million	-1.234x	-47.01%
2013-12-31	CHF70.87 Million ≈ $89.60 Million	CHF-59.47 Million ≈ $-75.19 Million	-0.839x	-159.74%
2012-12-31	CHF105.50 Million ≈ $133.38 Million	CHF148.17 Million ≈ $187.33 Million	1.404x	+361.31%
2011-12-31	CHF153.27 Million ≈ $193.77 Million	CHF-82.38 Million ≈ $-104.15 Million	-0.537x	-205.96%
2010-12-31	CHF210.24 Million ≈ $265.80 Million	CHF106.64 Million ≈ $134.82 Million	0.507x	+143.29%
2009-12-31	CHF97.73 Million ≈ $123.56 Million	CHF-114.51 Million ≈ $-144.77 Million	-1.172x	-84.04%
2008-12-31	CHF199.74 Million ≈ $252.53 Million	CHF-127.17 Million ≈ $-160.77 Million	-0.637x	-170.10%
2007-12-31	CHF335.10 Million ≈ $423.66 Million	CHF-78.99 Million ≈ $-99.86 Million	-0.236x	+63.47%
2006-12-31	CHF112.31 Million ≈ $141.99 Million	CHF-72.47 Million ≈ $-91.62 Million	-0.645x	-415.05%
2005-12-31	CHF167.87 Million ≈ $212.23 Million	CHF34.38 Million ≈ $43.47 Million	0.205x	+166.86%
2004-12-31	CHF209.60 Million ≈ $264.99 Million	CHF-64.20 Million ≈ $-81.17 Million	-0.306x	+47.24%
2003-12-31	CHF90.29 Million ≈ $114.15 Million	CHF-52.42 Million ≈ $-66.28 Million	-0.581x	-13.63%
2002-12-31	CHF125.38 Million ≈ $158.51 Million	CHF-64.07 Million ≈ $-81.00 Million	-0.511x	--

About Basilea Pharmaceutica AG

SW:BSLN Switzerland Biotechnology

Market Cap

$1.01 Billion

CHF802.69 Million CHF

Market Cap Rank

#10670 Global

#131 in Switzerland

Share Price

CHF65.40

Change (1 day)

-1.06%

52-Week Range

CHF44.90 - CHF66.70

All Time High

CHF108.80